Mary J. Janatpour
Senior VP & Chief Scientific OfficerMs. Mary J. Janatpour, Ph.D., is Senior Vice President and Chief Scientific Officer of Aptevo Therapeutics Inc. from May 2026. Ms. Janatpour leads Aptevo’s research and development strategy, with responsibility for advancing preclinical assets developed from the Company’s proprietary ADAPTIR™ and ADAPTIR-FLEX™ platforms and building a differentiated pipeline of cancer therapeutics. She brings more than countless years of biomedical research experience, including more than countless years helping biotechnology and pharmaceutical companies translate novel platforms into value-building oncology pipelines. Ms. Janatpour has held senior scientific leadership roles across established biopharmaceutical organizations and emerging biotechnology companies, giving her a rare combination of large-company oncology research discipline and hands-on experience building innovative programs in fast-moving development environments. Earlier in her career, she held leadership positions at the Novartis Institutes for Biomedical Research, Schering-Plough Biopharma and Chiron, where her work focused on oncology biologics target identification and validation. The latter half of her career has been focused on immuno-oncology. At Dynavax, she oversaw an immuno-oncology clinical program and research to inform rational combinations. Most recently she served as CSO at biotechnology companies developing novel platform-based approaches in immuno-oncology that included targeted in situ delivery of gene editors, as well as a bacterial vector platform. She also serves on the Board of Directors of Active Motif, is a scientific advisor to Mithrl and Cypre and has served as an independent consultant to immuno-oncology start-ups. Ms. Janatpour holds a BA in Molecular Biology from the University of California, Berkeley and a PhD in Biomedical Science from the University of California, San Francisco. She completed her postdoctoral training in Immunology at the DNAX Research Institute in Palo Alto, California.
Positions
- Company NameAptevo Therapeutics Inc.Stock CodeAPVOPositionSenior VP & Chief Scientific OfficerColleagues
- MLMarvin L. WhiteExecutive Chair
- JGJeffrey G. LamotheCEO, President & Director
- SKSoYoung KwonCorporate Secretary, Senior VP, General Counsel, Business Development & Corporate Affairs
- DLDaphne L. TaylorSenior VP & CFO
- ZPZsolt P. HarsanyiIndependent Director
- BLBarbara Lopez KunzIndependent Director
- JEJohn E. NiederhuberLead Independent Director
